Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Different γδ T cell types have unique roles in causing alopecia areata.

Etanercept may not prevent alopecia areata from coming back.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Targeting the AhR pathway may help treat alopecia areata.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Biodegradable scaffolds help regenerate wounds and hair by activating the immune system.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Abatacept may help some people with alopecia areata regrow hair.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.